in

CM Life Sciences, Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Pricing of Upsized $385 Million Initial Public Offering

New York, NY, September 1 2020 (Business Wire) — CM Life Sciences, Inc. (the “Company”) announced today that it priced its initial public offering of 38,500,000 units at $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “CMLFU” beginning September 2, 2020.

https://www.businesswire.com/news/home/20200901006148/en/CM-Life-Sciences-Sponsored-Affiliates-Casdin-Capital

What do you think?

Written by hsandm

Galectin Therapeutics Appoints Joel Lewis as Chief Executive Officer

Gilead commits $120M with $685M in future potential to Jounce